1. Home
  2. UNTY vs MNPR Comparison

UNTY vs MNPR Comparison

Compare UNTY & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$56.14

Market Cap

507.4M

Sector

Finance

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$65.64

Market Cap

531.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
MNPR
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.4M
531.6M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
UNTY
MNPR
Price
$56.14
$65.64
Analyst Decision
Buy
Strong Buy
Analyst Count
3
13
Target Price
$59.67
$97.83
AVG Volume (30 Days)
37.5K
165.4K
Earning Date
01-14-2026
11-13-2025
Dividend Yield
1.06%
N/A
EPS Growth
35.12
N/A
EPS
5.27
N/A
Revenue
$121,970,000.00
N/A
Revenue This Year
$24.41
N/A
Revenue Next Year
$11.16
N/A
P/E Ratio
$10.69
N/A
Revenue Growth
20.98
N/A
52 Week Low
$36.65
$21.00
52 Week High
$57.24
$105.00

Technical Indicators

Market Signals
Indicator
UNTY
MNPR
Relative Strength Index (RSI) 75.28 31.27
Support Level $55.35 $73.63
Resistance Level $57.24 $77.45
Average True Range (ATR) 1.76 5.34
MACD 0.33 -1.55
Stochastic Oscillator 86.16 4.01

Price Performance

Historical Comparison
UNTY
MNPR

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: